Approvals/TGA/CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe

Approved

STANDARD

CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe

Merck Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fe4f3dca41e1b42a
Product Name: CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Artg Id: 74888
Artg Name: CETROTIDE cetrorelix 250 microgram (as acetate) powder for injection vial with diluent syringe
Sponsor: Merck Healthcare Pty Ltd
Company Detail Path: /organization/merck-healthcare-pty-ltd
Artg Date: 2000-12-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5055399602a4cca902fcbc7853cfb9cc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1b4f9d3861488956df903cc933b7810f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

fe4f3dca41e1b42a

Type

Standard